Connected Wearable Patches Market by Product Type (Clinical Use, Non-Clinical Use); by Application (Monitoring, Detection & Diagnosis, Managing & Treatment, Health, Wellness & Prevention, Clinical Trials); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018-2026’
Industry Trends
Connected wearable patches include tags, tattoos, or small devices that are affixed to the skin and worn for a limited period of time, ranging from an hour to several weeks. The patches also have an element of wireless connectivity, and have a medical, health, or wellness purpose that can range from monitoring physiological data to delivering medication. The wearable technology devices are in high demand in the healthcare industry. Several connected wearable products are existing in various forms for many years. The development in wearable patches took place about a decade ago with the arrival of new sensors and low power radio chips. The market for connected wearable patches holds high demand, with the potential to improve the health of patients and contribute to lower healthcare costs. The market is however in the early stages of development and commercial availability. Advancements in the healthcare sector and growing health awareness worldwide is the primary factor driving the connected wearable patches market. The need to monitor health and fitness using wearable patches has also accentuated demand for the connected wearable patches. Growth in technological and medical capabilities is one of the major factor driving the growth of connected wearable patches market.
Connected Wearable Patches Market, By Region, 2018 – 2026, (USD Million)
In terms of revenue, the global connected wearable patches market was US$ 166820 Mn in 2017 and is estimated to be US$ 412470 Mn by 2022.
Connected Wearable Patches, by Application
Connected wearable patches are widely used in monitoring a patient’s conditions and treating them on time. They are also used in diagnosing any abnormalities in body conditions. For instance, people with diabetes prick their fingers multiple times a day to check their blood glucose levels, and dose themselves timely with injections of insulin. Monitoring is crucial, as rises in sugar levels in the blood can over time increase a diabetic patient’s risks of developing long-term complications from the disease. When a diabetic person puts the patch on, the device captures sweat from the person’s skin. Sensors within the patch pick up on the sweat's pH and note the temperature change that occurs. The patch then sends a signal alerting high glucose level to inform both, the patient as well as the doctor. Once a high level is detected, heaters in the patch start to dissolve a layer of coating, exposing micro needles that release a drug called Metformin, which help to regulate and reduce high blood sugar levels. This is how a patient’s health is monitored by using skin wearable patches. Such patches are also used in monitoring and treating other body conditions such as obesity, heart attack and increased blood pressure. In 2018, scientists from the Nanyang Technological University developed a micro-needle patch that delivers fat-burning drugs into the body. The researchers hope that their wearable patch could be used to address worldwide obesity problems without the need for surgical operations.
Connected Wearable Patches Market, by Region
North America is leading in connected wearable patches market, due to the technological advancements and high investments made by the companies in the region. As per the import data of United States, the shipment of wearable devices in the first quarter of 2015 in the United States reached US$11.4 million units. There was an increase of 200% as compared to previous years. Businesses are developing wearable patches that aim to make living with certain illnesses and conditions more manageable. For example, the ADAM (asthma detection and monitoring) wearable patch detects symptoms and, via an app connection, monitors inhaler use and provides warning of impending asthma attacks by sending important data to a patient’s doctor. North America based technology companies such as Intel and Apple are investing heavily in wearable patches. Also, non-tech companies such as Nike, Proteus Digital Health and others are investing heavily in connected wearable patches market.
Competitive Landscape
The report provides both, qualitative and quantitative research of the market, as well as strategic insights along with developments that are being adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisition (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their research institutes, competitors, product type, application and specification, pricing, and gross margin.
Connected wearable patches market participants include TempTraq, Qualcomm Inc., Abbott Laboratories, Nemaura Medical Inc., G-Tech Inc., Proteus Digital Health, Inc., Chrono Therapeutics, Blue Spark Technologies, KENZEN, Gentag Inc., Preventice Solutions, Vital Connect, Vancive Medical, Sensium Healthcare, Medtronic, NeuroMetrix, Qardio, iRhythm amongst others.
Connected Wearable Patches Market Background
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Connected Wearable Patches Market Snapshot
3. Executive Summary: Connected Wearable Patches Market
4. Qualitative Analysis: Connected Wearable Patches Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Market
5. Global Connected Wearable Patches Market Analysis and
Forecasts, 2018 – 2026
5.1. Overview
5.1.1. Global Market Revenue (US$ Mn) and Forecasts
5.2. Global Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
5.2.1. Clinical Use
5.2.1.1. Definition
5.2.1.2. Market Penetration
5.2.1.3. Market Revenue Expected to Increase by 2026
5.2.1.4. Compound Annual Growth Rate (CAGR)
5.2.2. Non-Clinical Use
5.2.2.1. Definition
5.2.2.2. Market Penetration
5.2.2.3. Market Revenue Expected to Increase by 2026
5.2.2.4. Compound Annual Growth Rate (CAGR)
5.3. Key Segment for Channeling Investments
5.3.1. By Product Type
6. Global Connected Wearable Patches Market Analysis and
Forecasts, 2018 – 2026
6.1. Overview
6.2. Global Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Application
6.2.1. Monitoring, Detection and Diagnosis
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Managing and Treatment
6.2.2.1. Definition
6.2.2.2. Market Penetration
6.2.2.3. Market Revenue Expected to Increase by 2026
6.2.2.4. Compound Annual Growth Rate (CAGR)
6.2.3. Health, Wellness and Prevention
6.2.3.1. Definition
6.2.3.2. Market Penetration
6.2.3.3. Market Revenue Expected to Increase by 2026
6.2.3.4. Compound Annual Growth Rate (CAGR)
6.2.4. Clinical Trials
6.2.4.1. Definition
6.2.4.2. Market Penetration
6.2.4.3. Market Revenue Expected to Increase by 2026
6.2.4.4. Compound Annual Growth Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By Application
7. North America Connected Wearable Patches Market Analysis and
Forecasts, 2018 – 2026
7.1. Overview
7.1.1. North America Market Revenue (US$ Mn)
7.2. North America Market Revenue (US$ Mn) and Forecasts, By
Product Type
7.2.1. Clinical Use
7.2.2. Non-Clinical Use
7.3. North America Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Application
7.3.1. Monitoring, Detection and Diagnosis
7.3.2. Managing and Treatment
7.3.3. Health, Wellness and Prevention
7.3.4. Clinical Trials
7.4. North America Market Revenue (US$ Mn) and Forecasts, By
Country
7.4.1. U.S.
7.4.1.1. U.S. Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
7.4.1.1.1. Clinical Use
7.4.1.1.2. Non-Clinical Use
7.4.1.2. U.S. Market Revenue (US$ Mn) and Forecasts, By Application
7.4.1.2.1. Monitoring, Detection and Diagnosis
7.4.1.2.2. Managing and Treatment
7.4.1.2.3. Health, Wellness and Prevention
7.4.1.2.4. Clinical Trials
7.4.2. Rest of North America
7.4.2.1. Rest of North America Market Revenue (US$ Mn) and Forecasts,
By Product Type
7.4.2.1.1. Clinical Use
7.4.2.1.2. Non-Clinical Use
7.4.2.2. Rest of North America Connected Wearable Patches Market
Revenue (US$ Mn) and Forecasts, By Application
7.4.2.2.1. Monitoring, Detection and Diagnosis
7.4.2.2.2. Managing and Treatment
7.4.2.2.3. Health, Wellness and Prevention
7.4.2.2.4. Clinical Trials
7.5. Key Segment for Channeling Investments
7.5.1. By Country
7.5.2. By Product Type
7.5.3. By Application
8. Europe Connected Wearable Patches Market Analysis and
Forecasts, 2018 – 2026
8.1. Overview
8.1.1. Europe Market Revenue (US$ Mn)
8.2. Europe Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.2.1. Clinical Use
8.2.2. Non-Clinical Use
8.3. Europe Market Revenue (US$ Mn) and Forecasts, By Application
8.3.1. Monitoring, Detection and Diagnosis
8.3.2. Managing and Treatment
8.3.3. Health, Wellness and Prevention
8.3.4. Clinical Trials
8.4. Europe Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Country
8.4.1. France
8.4.1.1. France Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.4.1.1.1. Clinical Use
8.4.1.1.2. Non-Clinical Use
8.4.1.2. France Market Revenue (US$ Mn) and Forecasts, By Application
8.4.1.2.1. Monitoring, Detection and Diagnosis
8.4.1.2.2. Managing and Treatment
8.4.1.2.3. Health, Wellness and Prevention
8.4.1.2.4. Clinical Trials
8.4.2. The UK
8.4.2.1. The UK Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.4.2.1.1. Clinical Use
8.4.2.1.2. Non-Clinical Use
8.4.2.2. The UK Market Revenue (US$ Mn) and Forecasts, By Application
8.4.2.2.1. Monitoring, Detection and Diagnosis
8.4.2.2.2. Managing and Treatment
8.4.2.2.3. Health, Wellness and Prevention
8.4.2.2.4. Clinical Trials
8.4.3. Spain
8.4.3.1. Spain Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.4.3.1.1. Clinical Use
8.4.3.1.2. Non-Clinical Use
8.4.3.2. Spain Market Revenue (US$ Mn) and Forecasts, By Application
8.4.3.2.1. Monitoring, Detection and Diagnosis
8.4.3.2.2. Managing and Treatment
8.4.3.2.3. Health, Wellness and Prevention
8.4.3.2.4. Clinical Trials
8.4.4. Germany
8.4.4.1. Germany Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.4.4.1.1. Clinical Use
8.4.4.1.2. Non-Clinical Use
8.4.4.2. Germany Market Revenue (US$ Mn) and Forecasts, By Application
8.4.4.2.1. Monitoring, Detection and Diagnosis
8.4.4.2.2. Managing and Treatment
8.4.4.2.3. Health, Wellness and Prevention
8.4.4.2.4. Clinical Trials
8.4.5. Italy
8.4.5.1. Italy Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
8.4.5.1.1. Clinical Use
8.4.5.1.2. Non-Clinical Use
8.4.5.2. Italy Market Revenue (US$ Mn) and Forecasts, By Application
8.4.5.2.1. Monitoring, Detection and Diagnosis
8.4.5.2.2. Managing and Treatment
8.4.5.2.3. Health, Wellness and Prevention
8.4.5.2.4. Clinical Trials
8.4.6. Rest of Europe
8.4.6.1. Rest of Europe Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Product Type
8.4.6.1.1. Clinical Use
8.4.6.1.2. Non-Clinical Use
8.4.6.2. Rest of Europe Market Revenue (US$ Mn) and Forecasts, By
Application
8.4.6.2.1. Monitoring, Detection and Diagnosis
8.4.6.2.2. Managing and Treatment
8.4.6.2.3. Health, Wellness and Prevention
8.4.6.2.4. Clinical Trials
8.5. Key Segment for Channeling Investments
8.5.1. By Country
8.5.2. By Product Type
8.5.3. By Application
9. Asia Pacific Connected Wearable Patches Market Analysis and
Forecasts, 2018 – 2026
9.1. Overview
9.1.1. Asia Pacific Market Revenue (US$ Mn)
9.2. Asia Pacific Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Product Type
9.2.1. Clinical Use
9.2.2. Non-Clinical Use
9.3. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By
Application
9.3.1. Monitoring, Detection and Diagnosis
9.3.2. Managing and Treatment
9.3.3. Health, Wellness and Prevention
9.3.4. Clinical Trials
9.4. Asia Pacific Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Country
9.4.1. China
9.4.1.1. China Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.4.1.1.1. Clinical Use
9.4.1.1.2. Non-Clinical Use
9.4.1.2. China Market Revenue (US$ Mn) and Forecasts, By Application
9.4.1.2.1. Monitoring, Detection and Diagnosis
9.4.1.2.2. Managing and Treatment
9.4.1.2.3. Health, Wellness and Prevention
9.4.1.2.4. Clinical Trials
9.4.2. Japan
9.4.2.1. Japan Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.4.2.1.1. Clinical Use
9.4.2.1.2. Non-Clinical Use
9.4.2.2. Japan Market Revenue (US$ Mn) and Forecasts, By Application
9.4.2.2.1. Monitoring, Detection and Diagnosis
9.4.2.2.2. Managing and Treatment
9.4.2.2.3. Health, Wellness and Prevention
9.4.2.2.4. Clinical Trials
9.4.3. India
9.4.3.1. India Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
9.4.3.1.1. Clinical Use
9.4.3.1.2. Non-Clinical Use
9.4.3.2. India Market Revenue (US$ Mn) and Forecasts, By Application
9.4.3.2.1. Monitoring, Detection and Diagnosis
9.4.3.2.2. Managing and Treatment
9.4.3.2.3. Health, Wellness and Prevention
9.4.3.2.4. Clinical Trials
9.4.4. Southeast Asia
9.4.4.1. Southeast Asia Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Product Type
9.4.4.1.1. Clinical Use
9.4.4.1.2. Non-Clinical Use
9.4.4.2. Southeast Asia Market Revenue (US$ Mn) and Forecasts, By
Application
9.4.4.2.1. Monitoring, Detection and Diagnosis
9.4.4.2.2. Managing and Treatment
9.4.4.2.3. Health, Wellness and Prevention
9.4.4.2.4. Clinical Trials
9.4.5. Rest of Asia Pacific
9.4.5.1. Rest of Asia Pacific Connected Wearable Patches Market Revenue
(US$ Mn) and Forecasts, By Product Type
9.4.5.1.1. Clinical Use
9.4.5.1.2. Non-Clinical Use
9.4.5.2. Rest of Asia Pacific Market Revenue (US$ Mn) and Forecasts, By
Application
9.4.5.2.1. Monitoring, Detection and Diagnosis
9.4.5.2.2. Managing and Treatment
9.4.5.2.3. Health, Wellness and Prevention
9.4.5.2.4. Clinical Trials
9.5. Key Segment for Channeling Investments
9.5.1. By Country
9.5.2. By Product Type
9.5.3. By Application
10. Middle East and Africa Connected Wearable Patches Market
Analysis and Forecasts, 2018 – 2026
10.1. Overview
10.1.1. Middle East and Africa Market Revenue (US$ Mn)
10.2. Middle East and Africa Connected Wearable Patches Market
Revenue (US$ Mn) and Forecasts, By Product Type
10.2.1. Clinical Use
10.2.2. Non-Clinical Use
10.3. Middle East and Africa Revenue (US$ Mn) and Forecasts, By
Application
10.3.1. Monitoring, Detection and Diagnosis
10.3.2. Managing and Treatment
10.3.3. Health, Wellness and Prevention
10.3.4. Clinical Trials
10.4. Middle East and Africa Connected Wearable Patches Market
Revenue (US$ Mn) and Forecasts, By Country
10.4.1. GCC Countries
10.4.1.1. GCC Market Revenue (US$ Mn) and Forecasts, By Product Type
10.4.1.1.1. Clinical Use
10.4.1.1.2. Non-Clinical Use
10.4.1.2. GCC Countries Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Application
10.4.1.2.1. Monitoring, Detection and Diagnosis
10.4.1.2.2. Managing and Treatment
10.4.1.2.3. Health, Wellness and Prevention
10.4.1.2.4. Clinical Trials
10.4.2. Southern Africa
10.4.2.1. Southern Africa Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Product Type
10.4.2.1.1. Clinical Use
10.4.2.1.2. Non-Clinical Use
10.4.2.2. Southern Africa Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.2.2.1. Monitoring, Detection and Diagnosis
10.4.2.2.2. Managing and Treatment
10.4.2.2.3. Health, Wellness and Prevention
10.4.2.2.4. Clinical Trials
10.4.3. Rest of MEA
10.4.3.1. Rest of MEA Connected Wearable Patches Market Revenue (US$ Mn)
and Forecasts, By Product Type
10.4.3.1.1. Clinical Use
10.4.3.1.2. Non-Clinical Use
10.4.3.2. Rest of MEA Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.3.2.1. Monitoring, Detection and Diagnosis
10.4.3.2.2. Managing and Treatment
10.4.3.2.3. Health, Wellness and Prevention
10.4.3.2.4. Clinical Trials
10.5. Key Segment for Channeling Investments
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Application
11. Latin America Connected Wearable Patches Market Analysis and
Forecasts, 2018 – 2026
11.1. Overview
11.1.1. Latin America Market Revenue (US$ Mn)
11.2. Latin America Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Product Type
11.2.1. Clinical Use
11.2.2. Non-Clinical Use
11.3. Latin America Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.1. Monitoring, Detection and Diagnosis
11.3.2. Managing and Treatment
11.3.3. Health, Wellness and Prevention
11.3.4. Clinical Trials
11.4. Latin America Connected Wearable Patches Market Revenue (US$
Mn) and Forecasts, By Country
11.4.1. Brazil
11.4.1.1. Brazil Connected Wearable Patches Market Revenue (US$ Mn) and
Forecasts, By Product Type
11.4.1.1.1. Clinical Use
11.4.1.1.2. Non-Clinical Use
11.4.1.2. Brazil Market Revenue (US$ Mn) and Forecasts, By Application
11.4.1.2.1. Monitoring, Detection and Diagnosis
11.4.1.2.2. Managing and Treatment
11.4.1.2.3. Health, Wellness and Prevention
11.4.1.2.4. Clinical Trials
11.4.2. Rest of Latin America
11.4.2.1. Rest of Latin America Connected Wearable Patches Market
Revenue (US$ Mn) and Forecasts, By Product Type
11.4.2.1.1. Clinical Use
11.4.2.1.2. Non-Clinical Use
11.4.2.2. Rest of Latin America Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.2.2.1. Monitoring, Detection and Diagnosis
11.4.2.2.2. Managing and Treatment
11.4.2.2.3. Health, Wellness and Prevention
11.4.2.2.4. Clinical Trials
11.5. Key Segment for Channeling Investments
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Application
12. Competitive Benchmarking
12.1. Player Positioning Analysis
12.2. Global Presence and Growth Strategies
13. Player Profiles
13.1. Abbott Laboratories
13.1.1. Company Details
13.1.2. Company Overview
13.1.3. Product Offerings
13.1.4. Key Developments
13.1.5. Financial Analysis
13.1.6. SWOT Analysis
13.1.7. Business Strategies
13.2. Blue Spark Technologies
13.2.1. Company Details
13.2.2. Company Overview
13.2.3. Product Offerings
13.2.4. Key Developments
13.2.5. Financial Analysis
13.2.6. SWOT Analysis
13.2.7. Business Strategies
13.3. Chrono Therapeutics
13.3.1. Company Details
13.3.2. Company Overview
13.3.3. Product Offerings
13.3.4. Key Developments
13.3.5. Financial Analysis
13.3.6. SWOT Analysis
13.3.7. Business Strategies
13.4. G-Tech Inc.
13.4.1. Company Details
13.4.2. Company Overview
13.4.3. Product Offerings
13.4.4. Key Developments
13.4.5. Financial Analysis
13.4.6. SWOT Analysis
13.4.7. Business Strategies
13.5. iRhythm
13.5.1. Company Details
13.5.2. Company Overview
13.5.3. Product Offerings
13.5.4. Key Developments
13.5.5. Financial Analysis
13.5.6. SWOT Analysis
13.5.7. Business Strategies
13.6. KENZEN, Gentag Inc.
13.6.1. Company Details
13.6.2. Company Overview
13.6.3. Product Offerings
13.6.4. Key Developments
13.6.5. Financial Analysis
13.6.6. SWOT Analysis
13.6.7. Business Strategies
13.7. Medtronic
13.7.1. Company Details
13.7.2. Company Overview
13.7.3. Product Offerings
13.7.4. Key Developments
13.7.5. Financial Analysis
13.7.6. SWOT Analysis
13.7.7. Business Strategies
13.8. NeuroMetrix
13.8.1. Company Details
13.8.2. Company Overview
13.8.3. Product Offerings
13.8.4. Key Developments
13.8.5. Financial Analysis
13.8.6. SWOT Analysis
13.8.7. Business Strategies
13.9. Nemaura Medical Inc.
13.9.1. Company Details
13.9.2. Company Overview
13.9.3. Product Offerings
13.9.4. Key Developments
13.9.5. Financial Analysis
13.9.6. SWOT Analysis
13.9.7. Business Strategies
13.10. Preventice Solutions
13.10.1. Company Details
13.10.2. Company Overview
13.10.3. Product Offerings
13.10.4. Key Developments
13.10.5. Financial Analysis
13.10.6. SWOT Analysis
13.10.7. Business Strategies
13.11. Proteus Digital Health, Inc.
13.11.1.
Company Details
13.11.2.
Company Overview
13.11.3.
Product Offerings
13.11.4.
Key Developments
13.11.5.
Financial Analysis
13.11.6.
SWOT Analysis
13.11.7.
Business Strategies
13.12. Qardio
13.12.1.
Company Details
13.12.2.
Company Overview
13.12.3.
Product Offerings
13.12.4.
Key Developments
13.12.5.
Financial Analysis
13.12.6.
SWOT Analysis
13.12.7.
Business Strategies
13.13. Qualcomm Inc.
13.13.1.
Company Details
13.13.2.
Company Overview
13.13.3.
Product Offerings
13.13.4.
Key Developments
13.13.5.
Financial Analysis
13.13.6.
SWOT Analysis
13.13.7. Business Strategies
13.14. Sensium Healthcare
13.14.1.
Company Details
13.14.2.
Company Overview
13.14.3.
Product Offerings
13.14.4.
Key Developments
13.14.5.
Financial Analysis
13.14.6.
SWOT Analysis
13.14.7. Business Strategies
13.15. TempTraq
13.15.1.
Company Details
13.15.2.
Company Overview
13.15.3.
Product Offerings
13.15.4.
Key Developments
13.15.5.
Financial Analysis
13.15.6.
SWOT Analysis
13.15.7.
Business Strategies
13.16. Vital Connect
13.16.1.
Company Details
13.16.2.
Company Overview
13.16.3.
Product Offerings
13.16.4.
Key Developments
13.16.5.
Financial Analysis
13.16.6.
SWOT Analysis
13.16.7.
Business Strategies
13.17. Vancive Medical
13.17.1.
Company Details
13.17.2.
Company Overview
13.17.3.
Product Offerings
13.17.4.
Key Developments
13.17.5.
Financial Analysis
13.17.6. SWOT Analysis
13.17.7.
Business Strategies
Note:
This ToC is tentative and can be changed according to the research study
conducted during the course of report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
